In a subsequent Phase Ib study, the same group investigated whether BRBs might regress rectal polyps in patients with familial adenomatous polyposis (FAP), a genetic disease caused by a mutation of the APC gene and characterized by rectal polyps detectable at a young age and high risk for developing colon cancer [52]. This evidence concerns the gene APC and rectal hyperplastic polyp.